Investment
Features
FeesSafety
Academy
More
Pluang+

Compare SoFi Technologies Inc (SOFI) vs Tenet Healthcare Corporation (THC) Price & Performance

SoFi Technologies IncTrade
Tenet Healthcare CorporationTrade

Price performance (Past 24H)

Key statistics

SoFi Technologies Inc vs Tenet Healthcare Corporation — how do they compare? SoFi Technologies Inc trades at $15.8 (market cap $20.16B), while Tenet Healthcare Corporation trades at $263.45 (market cap $20.98B). The key difference: SoFi Technologies Inc and Tenet Healthcare Corporation are close in size by market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, SoFi Technologies Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold SoFi Technologies Inc for 60 Days and Tenet Healthcare Corporation for 15 Days on average.

SOFITHC
Market Cap
$20.16B$20.98B
Volume
49,646,331428,008
Sector
FinancialsHealth
52-Week High
$32.21$280.77
52-Week Low
$15.15$161.37
Typical Hold Time
60 Days15 Days
Enterprise Value
$20.30B$32.06B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

SoFi Technologies Inc

SoFi Technologies (SOFI) trades at $15.72, up 0.38% on the day, but remains near 52-week lows amid a bearish technical outlook. The company reported strong revenue growth, with 2025 revenue reaching $3.61 billion and net income of $481.32 million, though cash flow from operations remains negative. Analyst consensus is mixed with a $21.58 price target, but technical indicators signal caution.

SoFi's growth trajectory and improving profitability present long-term potential, but near-term risks include persistent negative operating cash flow, high valuation multiples, and sensitivity to interest rates. Execution on loan originations and stablecoin initiatives will be critical for stock performance.

Tenet Healthcare Corporation

Tenet Healthcare (THC) trades at $265.42, up 2.15% today, with a bullish technical signal from moving averages and strong support near $257. The company shows robust fundamentals, including a 53.31% ROE and consistent earnings beats, with Q3 2026 results due October 29. Revenue growth is supported by higher revenue per case despite softer surgical volumes, as noted by Zacks on September 24, 2026.

The outlook is positive, with an 81.25% analyst buy rating and a $283.36 consensus price target implying ~7% upside. Risks include sustainability of capital returns amid growth investments and potential volume pressures, but solid cash flow and valuation metrics like a 10.07 P/E suggest room for appreciation if execution continues.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SOFI
69% Buy31% Sell
Avg holding period · 60 Days
THC

No sentiment data available yet.

Top news

Latest headlines on both assets

About SoFi Technologies Inc

SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.

Read more on SOFI →

About Tenet Healthcare Corporation

Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.

Read more on THC →